50,000 Safer is a program to increase pharmacogenetic testing access for thousands of at-risk patients and their families who live in the U.S. The program is based on the idea that, with predictive science, safer prescribing is possible – – reducing poor medication-related health outcomes and hospitalizations.
- Eligibility: Find out if pharmacogenetic testing is right for you
- Frequently Asked Questions (FAQs)
- For general questions about the program, email email@example.com or call (919) 945-6875
Learn more about the science of pharmacogenetics
Watch this video from the PRIME Care team over at the Veterans Health Administration for their take on pharmacogenetics.
Other resources about pharmacogenomics & pharmacogenetics:
- What is pharmacogenomics? Check out how the NIH-funded PharmGKB resource describes it, why it is important, and how some clinicians are using this science to better treat their patients.
- The U.S. Food & Drug Administration (FDA) notes “Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose.” To read the list of medications with pharmacogenomic information on their drug labels, visit: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
- Health insurance companies and employers are prohibited from discriminating based on genetic test results by statutes enacted by the U.S. federal government. The same laws forbid genetic information to be disclosed without authorization. To learn more about the laws protecting your genetic information: https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination